Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TelePeptide vs Whoosh Wellness

TelePeptide
Graded #276

Lower grade

vs+1.7999999999999972
Whoosh Wellness
Graded #248

Higher grade

The verdict

Whoosh Wellness takes it — 64.1/100 to 62.3/100, but only just.

Whoosh Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Whoosh Wellness is a physician-guided GLP-1 and peptide telehealth service offering compounded semaglutide (from $187/mo) and tirzepatide (from $235/mo), with everything bundled into one price — physician… TelePeptide is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWhoosh Wellness +8
44
52
Dose & formulationWhoosh Wellness +2
75
77
Clinical oversightTelePeptide +7
87
80
Labs & monitoringTelePeptide +1
54
53
FulfillmentTelePeptide +1
77
76
Contract termsWhoosh Wellness +13
20
33
TelePeptide · left barWhoosh Wellness · right bar

The numbers

MetricTelePeptideWhoosh Wellness
WeighScore62.3/10064.1/100
GradeCC
Scorecard rank#276#248
Semaglutide$199/mo (starting dose, annual plan, compounded oral)$187/mo (compounded)
Tirzepatide$219/mo (starting dose, annual plan, compounded oral)$235/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
TelePeptide

Graded #276 · C

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
  • Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

Where it loses points

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average
Whoosh Wellness

Graded #248 · C

Strengths

  • All-inclusive pricing — physician review, supplies, and free shipping bundled into one monthly price; no charge until prescribed
  • Compounded semaglutide from $187/mo and tirzepatide from $235/mo (lower on 3- and 6-month plans)
  • Pharmacy-grade 503A/503B compounding with third-party batch testing; supplies (syringes, swabs) included
  • Physician-led with 24/7 ongoing provider access and monthly check-ins; also offers sermorelin, NAD+ and glutathione

Where it loses points

  • Best rates require a 3- or 6-month commitment; month-to-month starts at $187 (semaglutide) / $235 (tirzepatide)
  • Doesn't name its specific compounding pharmacy partners
  • No explicit state-coverage list or LegitScript certification shown on the site
  • Compounded GLP-1s are not FDA-approved

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard